GB0410702D0 - Targeting GCP-2 - Google Patents
Targeting GCP-2Info
- Publication number
- GB0410702D0 GB0410702D0 GB0410702A GB0410702A GB0410702D0 GB 0410702 D0 GB0410702 D0 GB 0410702D0 GB 0410702 A GB0410702 A GB 0410702A GB 0410702 A GB0410702 A GB 0410702A GB 0410702 D0 GB0410702 D0 GB 0410702D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- gcp
- targeting
- targeting gcp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 101710085504 C-X-C motif chemokine 6 Proteins 0.000 title 1
- 102100028605 Gamma-tubulin complex component 2 Human genes 0.000 title 1
- 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0410702A GB0410702D0 (en) | 2004-05-13 | 2004-05-13 | Targeting GCP-2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0410702A GB0410702D0 (en) | 2004-05-13 | 2004-05-13 | Targeting GCP-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0410702D0 true GB0410702D0 (en) | 2004-06-16 |
Family
ID=32526993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0410702A Ceased GB0410702D0 (en) | 2004-05-13 | 2004-05-13 | Targeting GCP-2 |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0410702D0 (en) |
-
2004
- 2004-05-13 GB GB0410702A patent/GB0410702D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205935A1 (en) | Non-lithotripsic kidney-stone therapy | |
EP1913543A4 (en) | Budget-based advertisement placement | |
GB0520794D0 (en) | Inhaler | |
GB0519151D0 (en) | Inhaler | |
IL191850A0 (en) | Targeting vector-phospholipid conjugates | |
EP1949016A4 (en) | Precision targeting | |
EP1859828A4 (en) | Inhaler | |
GB0526449D0 (en) | Polypeptide targeting | |
GB0504206D0 (en) | Combination therapy | |
GB0509052D0 (en) | Combination therapy | |
ZA200709627B (en) | Combination therapy | |
GB0507003D0 (en) | Therapeutic | |
GB0518720D0 (en) | Therapeutic combination | |
TWI372053B (en) | Combination drug | |
GB0510091D0 (en) | Inhaler | |
GB0410816D0 (en) | Targeting GCP-2 | |
GB0410702D0 (en) | Targeting GCP-2 | |
GB2429354B (en) | Fiber-to-the-premise architectures | |
GB0419983D0 (en) | Improved targeting device | |
GB0402471D0 (en) | Improved targeting device | |
GB0406408D0 (en) | Targeting polypeptide | |
GB0412419D0 (en) | Targeting polypeptide | |
GB0502541D0 (en) | Medicament | |
SI1966388T1 (en) | Targeting vector-phospholipid conjugates | |
GB0501892D0 (en) | Game |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |